2011-05-30 CBCS Officially Launched at PCB2011
Monday, May 30, 2011 at 5:18PM Stockholm, Sweden 2011-05-30
Chemical Biology Consortium Sweden officially launched in connection with the Perspectives in Chemical Biology 2011 symposium
Professor Stuart L. Schreiber of the Broad Institute of MIT & Harvard and Dr. Chas Bountra of the Structural Genomics Consortium Oxford were two of the distinguished speakers that helped officially launch Chemical Biology Consortium Sweden (CBCS) at the organization’s first national meeting held at KI on May 19th 2011. The Perspectives in Chemical Biology 2011 (PCB2011) symposium, sponsored by AstraZeneca, Perkin Elmer and Schrödinger, was attended by nearly 200 participants and featured scientific presentations by opinion-leaders from Oxford University, Dundee University, University of Olso, Stockholm University, University of Gothenburg, Karolinska Institutet, Lund University, Uppsala University and Umeå University.
The symposium was concluded by an inaugural address by Karolinska Institutet president Harriet Wallberg-Henriksson who officially announced initiation of the consortium’s activities and the opening of the newly built Laboratories for Chemical Biology Karolinska Instituet (LCBKI). The event was followed by the first meeting of the CBCS board on Friday the 20th. Although PCB2011 marked the official launch of CBCS, the consortium has been actively engaged in collaborative projects with academic groups in Sweden since mid-2010 when funding for the infrastructure was finalized from the National Research Council.
About CBCS
Chemical Biology Consortium Sweden (CBCS) was established in 2010 as a government-funded, non-profit strategic resource for academic researchers across Sweden. CBCS consists of nodes at Karolinska Institutet, Umeå University and Uppsala University. The organization coordinates, and makes available, a powerful academic framework of infrastructures for the discovery, development and utilization of small-molecules and molecular probes for life-science applications. CBCS provides expertise within assay development, computational chemistry, cheminformatics, chemical library screening, medicinal chemistry, and preclinical profiling. By providing access to state-of-the-art science and technology, CBCS aims to help Swedish academia towards new discoveries in fundamental aspects of biology. For more information visit www.cbcs.se.
For more information please contact:
Dr. Annika Jenmalm Jensen
Director, CBCS
+46 704107163
annika.jenmalm-jensen@ki.se
